Skip to Main Content

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?

And here is our regular feature in which we highlight a different person each week. This time around, we note that Pacira Pharmaceuticals hired Robert Weiland as chief commercial officer. Most recently, he was vice president of strategy at Baxter International. Before that, he was vice president for commercial operations and strategic analytics at Takeda Pharmaceuticals. He also spent 14 years at Abbott Laboratories.

Xenon Pharmaceuticals hired Raymond Winquist as head of translational research;


Warp Drive Bio hired Alan Rigby as chief scientific officer;

Astellas hired Joseph Fleishaker as VP, clinical pharmacology and exploratory development;


Eisai hired Paul Hawthorne as senior vice president, US commercial, neurology business group;

Anika Therapeutics hired Dr. Stephen Mascioli as chief medical officer;

Anika Therapeutics hired Dana Alexander as chief operations officer;

Anika Therapeutics hired Jean Bjerke as vice president of marketing;

Lupin hired Kurt Nielsen as head of its Gavis-Novel Somerset business;

Nuvo Pharmaceuticals hired Jesse Ledger as vice president, business development;

Athenex hired Dr. David Cutler as vice president of clinical development;

Ra Pharmaceuticals hired Simon Read as chief scientific officer;

AAT Research hired Wolfgang Storf as chief executive officer;

PhaseBio Pharmaceuticals hired Dr. John Lee as chief medical officer;

PhaseBio Pharmaceuticals hired John Sharp as chief financial officer;

Tris Pharma hired Sharon Clarke as chief commercial officer;

Aimmune Therapeutics hired Douglas Sheehy as general counsel;

InCarda Therapeutics hired Dr. Luiz Belardinelli as chief medical officer;

ImmunoGen said Daniel Junius will retire as chief executive officer and president;

Sorrento Therapeutics hired Kevin Herde as executive vice president and chief financial officer;

Veloxis Pharmaceuticals said Johnny Stilou will step down as executive VP and chief financial officer;

Remedy Pharmaceuticals hired Dr. Thomas Zimmerman Jr. as vice president, medical affairs; hired Kelly Ann Barnes as VP of pharmacy verification and information;

Intarcia Therapeutics hired Anthony Hurley as VP, global commercial manufacturing and operations.